Although the clinical implications of these findings are limited, they confirm that indirect immune modulation by cytotoxic agents [25, 26] could enhance CD8+ T‐cell activity induced by PD‐1/PD‐L1 inhibitors [27] and promote anti‐tumour responses. Here, CD8A is linked to neoplasm.